Bank of America’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank of America’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-130,000	Closed	-$624K	–	7938
2020 Q4	$624K	Buy	+130,000	New	+$658K	﹤0.01%	4851
2020 Q2	–	Sell	-200,000	Closed	-$1.27M	–	7253
2020 Q1	$1.27M	Sell	200,000 -1,200,000	-86%	-$9.63M	﹤0.01%	3857
2019 Q4	$14.6M	Buy	+1,400,000	New	+$10.2M	﹤0.01%	2184
2019 Q1	–	Sell	-21,100	Closed	-$379K	–	7521
2018 Q4	$379K	Sell	21,100 -700	-3%	-$14.3K	﹤0.01%	5117
2018 Q3	$640K	Hold	21,800	–	–	﹤0.01%	4784
2018 Q2	$991K	Hold	21,800	–	–	﹤0.01%	4478
2018 Q1	$1.15M	Sell	21,800 -39,800	-65%	-$2.32M	﹤0.01%	4297
2017 Q4	$4.19M	Buy	61,600 +27,900	+83%	+$1.95M	﹤0.01%	3288
2017 Q3	$2.78M	Sell	33,700 -121,100	-78%	-$9.6M	﹤0.01%	3707
2017 Q2	$14.5M	Buy	154,800 +68,800	+80%	+$4.21M	﹤0.01%	2021
2017 Q1	$5.48M	Buy	+86,000	New	+$5.23M	﹤0.01%	2936

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America's CLVS Position: Q4 2022 in Review

Bank of America sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 10,958 shares — an estimated $13K sold.

Bank of America first reported a position in CLVS in Q2 2013 and held it in 38 quarters. The position peaked at $60.6M in Q2 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Bank of America reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Bank of America sold 10,958 Clovis Oncology, Inc. shares in Q4 2022, an estimated $13K.
Bank of America first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 38 quarters.
Bank of America's Clovis Oncology, Inc. position peaked at $60.6M in Q2 2017.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.